Goldman Sachs’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $965K | Buy |
442,579
+155,751
| +54% | +$340K | ﹤0.01% | 3868 |
|
|
2025
Q1 | $783K | Sell |
286,828
-232,210
| -45% | -$634K | ﹤0.01% | 3980 |
|
|
2024
Q4 | $2.16M | Buy |
519,038
+13,650
| +3% | +$56.8K | ﹤0.01% | 3421 |
|
|
2024
Q3 | $1.97M | Buy |
505,388
+157,535
| +45% | +$613K | ﹤0.01% | 3385 |
|
|
2024
Q2 | $1.36M | Buy |
347,853
+162,994
| +88% | +$639K | ﹤0.01% | 3436 |
|
|
2024
Q1 | $775K | Sell |
184,859
-12,569
| -6% | -$52.7K | ﹤0.01% | 3764 |
|
|
2023
Q4 | $928K | Buy |
197,428
+14,392
| +8% | +$67.6K | ﹤0.01% | 3653 |
|
|
2023
Q3 | $571K | Buy |
183,036
+17,669
| +11% | +$55.1K | ﹤0.01% | 3837 |
|
|
2023
Q2 | $759K | Buy |
165,367
+30,147
| +22% | +$138K | ﹤0.01% | 3766 |
|
|
2023
Q1 | $669K | Buy |
135,220
+12,280
| +10% | +$60.8K | ﹤0.01% | 3918 |
|
|
2022
Q4 | $671K | Sell |
122,940
-335,480
| -73% | -$1.83M | ﹤0.01% | 3924 |
|
|
2022
Q3 | $2.98M | Sell |
458,420
-833,822
| -65% | -$5.42M | ﹤0.01% | 3045 |
|
|
2022
Q2 | $6.11M | Buy |
1,292,242
+288,504
| +29% | +$1.36M | ﹤0.01% | 2501 |
|
|
2022
Q1 | $7.02M | Buy |
1,003,738
+763,344
| +318% | +$5.34M | ﹤0.01% | 2528 |
|
|
2021
Q4 | $2.45M | Buy |
240,394
+84,011
| +54% | +$856K | ﹤0.01% | 3355 |
|
|
2021
Q3 | $1.91M | Buy |
+156,383
| New | +$1.91M | ﹤0.01% | 3528 |
|